美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

科興生物

6.47

0.0000

成交量：- -

成交額：- -

市值：4.65億

市盈率：-4.72

高：6.47

開：6.47

低：6.47

收：6.47

52周最高：6.47

52周最低：6.47

股本：7,186.07萬

流通股本：3,116.90萬

量比：0.52

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):-1.3700

每股收益(LYR):1.06

淨資產收益率：25.15%

總資產收益率：11.46%

市淨率：0.62

市盈率(LYR):6.13

資料載入中...

總覽公司新聞公告

科興生物宣佈延長先前宣佈的特別現金股息支付指令提交截止日期

科興生物退市警報暫解虧損與監管壓力懸頂

停牌7年後，科興生物重新滿足納斯達克持續上市要求，退市警報暫時解除

每日经济新闻

科興生物宣佈延長此前宣佈的特別現金股息付款指示提交截止日期

科興生物發布2025年半年報，納斯達克摘牌風險暫解

科興生物：2025上半年營收1.303億美元，研發投入1.27億美元

南方财经网

科興控股上半年海外營收大增近三成，對沖國內市場下滑

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/SVA/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"SVA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SVA\",,,,,undefined,":{"symbol":"SVA","market":"US","secType":"STK","nameCN":"科興生物","latestPrice":6.47,"timestamp":1789156800000,"preClose":6.47,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":31169000,"shares":71860702,"eps":-1.37,"marketStatus":"停牌","change":0,"latestTime":"09-11 16:00:00 EDT","open":6.47,"high":6.47,"low":6.47,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.37,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1102482000000,"exchange":"NASDAQ","adjPreClose":6.47,"volumeRatio":0.5219117885997689},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SVA\",,,,,undefined,":{"symbol":"SVA","floatShares":31169000,"roa":"11.46%","roe":"25.15%","lyrEps":1.055174,"volumeRatio":0.5219117885997689,"shares":71860702,"dividePrice":0,"high":6.47,"amplitude":0,"preClose":6.47,"low":6.47,"week52Low":6.47,"pbRate":"0.62","week52High":6.47,"institutionHeld":0.1883,"latestPrice":6.47,"eps":-1.37,"divideRate":0,"volume":0,"delay":0,"ttmEps":-1.37,"open":6.47,"prevYearClose":6.47,"prevWeekClose":6.47,"prevMonthClose":6.47,"prevQuarterClose":6.47,"fiveDayClose":6.47,"twentyDayClose":6.47,"sixtyDayClose":6.47},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SVA\",params:#limit:5,,,undefined,":[{"date":"2025-07-08","symbol":"SVA","amount":55,"announcedDate":"2025-04-01","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-23","defaultRemindTime":1751981400000,"name":"科兴生物","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-07","payableDate":"2025-05-23","currency":"USD","dateTimestamp":1751947200000,"payDate":"2025-07-07"},{"market":"US","date":"2022-04-29","symbol":"SVA","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1651204800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2021-12-31","symbol":"SVA","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1640926800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2021-09-17","symbol":"SVA","fiscalQuarterEnding":"2021/06","expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1631851200000,"reportTimeType":"post","actualEps":-0.05},{"market":"US","date":"2021-06-29","symbol":"SVA","fiscalQuarterEnding":"2021/03","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1624939200000,"reportTimeType":"","actualEps":-0.07}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SVA\",market:\"US\",,,undefined,":[{"executeDate":"2025-07-08","recordDate":"2025-05-23","paymentDate":"2025-07-07","value":55,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SVA\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SVA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SVA","date":"2021-09-21","current":-4.722628,"percent":0.24257,"low":-100.201212,"twenty":-62.345712,"median":22.039362,"eighty":29.57901,"high":42.074882,"avg":0.136365,"sd":42.133061,"marketCap":642436987},"quantilePoints":[{"date":"2021-09-17","current":5.82081,"twenty":-62.345712,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-09-24","current":5.82081,"twenty":-62.345712,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-10-01","current":5.82081,"twenty":-62.345712,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-10-08","current":5.82081,"twenty":-62.345712,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-10-15","current":5.82081,"twenty":-62.345712,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-10-22","current":5.82081,"twenty":-62.345712,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-10-29","current":5.82081,"twenty":-62.119913,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-11-05","current":5.82081,"twenty":-62.119913,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-11-09","current":5.82081,"twenty":-62.119913,"median":22.039362,"eighty":29.57901,"marketCap":642436987}],"updateTime":1789314048815},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SVA\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1107188981","title":"科興生物宣佈延長先前宣佈的特別現金股息支付指令提交截止日期","url":"https://stock-news.laohu8.com/highlight/detail?id=1107188981","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107188981?lang=zh_tw&edition=fundamental","pubTime":"2026-07-15 14:00","pubTimestamp":1784095234,"startTime":"0","endTime":"0","summary":"科兴生物宣布，针对此前已宣告的特别现金股息，公司决定延长股东提交支付指令的截止日期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SVA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644797458","title":"科興生物退市警報暫解 虧損與監管壓力懸頂","url":"https://stock-news.laohu8.com/highlight/detail?id=2644797458","media":"央广财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644797458?lang=zh_tw&edition=fundamental","pubTime":"2026-06-17 11:27","pubTimestamp":1781666850,"startTime":"0","endTime":"0","summary":"央广网北京6月17日消息（记者邹煦晨）经过十年内斗的科兴生物（SVA.O），退市警报暂时解除。6月15日晚间，该公司发布公告表示，已于6月5日递交2025财年20-F表格年度报告，并收到纳斯达克听证顾问出具的通知函。函件确认，公司当前满足纳斯达克全球市场持续上市相关标准。不过，公司仍处于强制小组监督阶段，该期限将持续至2027年5月20日。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606173774300020.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606173774300020.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["SVA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643780556","title":"停牌7年後，科興生物重新滿足納斯達克持續上市要求，退市警報暫時解除","url":"https://stock-news.laohu8.com/highlight/detail?id=2643780556","media":"每日经济新闻","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643780556?lang=zh_tw&edition=fundamental","pubTime":"2026-06-16 09:48","pubTimestamp":1781574480,"startTime":"0","endTime":"0","summary":"6月15日晚间，科兴生物（Nasdaq：SVA）公告称，公司已于6月5日提交2025年20-F表格年度报告，并收到纳斯达克听证顾问的通知函，确认公司目前符合纳斯达克全球市场持续上市要求。但公司仍处于强制“小组监督期”内，直至2027年5月20日。自2019年2月22日起，科兴生物普通股在纳斯达克的交易因股东权利计划争议被暂停，至今仍未恢复。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606163772539337.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606163772539337.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4139","SVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128905472","title":"科興生物宣佈延長此前宣佈的特別現金股息付款指示提交截止日期","url":"https://stock-news.laohu8.com/highlight/detail?id=1128905472","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128905472?lang=zh_tw&edition=fundamental","pubTime":"2026-05-21 18:33","pubTimestamp":1779359607,"startTime":"0","endTime":"0","summary":"科兴生物宣布，将延长此前已宣布的特别现金股息的付款指示提交截止日期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634869497","title":"科興生物發布2025年半年報，納斯達克摘牌風險暫解","url":"https://stock-news.laohu8.com/highlight/detail?id=2634869497","media":"新京报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634869497?lang=zh_tw&edition=fundamental","pubTime":"2026-05-09 15:36","pubTimestamp":1778312208,"startTime":"0","endTime":"0","summary":"5月8日晚间，科兴生物（纳斯达克股票代码：SVA）披露2025年半年度财报（未经审计），报告期内，公司销售收入1.3亿美元，同比微增1.24%；归属于普通股股东的净亏损为2170万美元。研发投入1.27亿美元，占同期营收比激增至97.4%。截至目前，科兴生物已完成纳斯达克要求的截至2024年年报及2025年半年报的报送，摘牌风险暂时解除。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605093732214995.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605093732214995.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["TQQQ","QQQA","SQQQ","PSQ","BK4007","MNQmain","BK4139","QID","IYW","ARTL","TECS","QQQY","03086","159632","QQQE","GPIQ","QDTE","SVA","QQQM","JEPQ","NVIW.SI","QQQ","FTEC","BK1147",".IXIC","TQQY","NQmain","QLD","QQQJ","ONEQ","QYLG","NDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634998724","title":"科興生物：2025上半年營收1.303億美元，研發投入1.27億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2634998724","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634998724?lang=zh_tw&edition=fundamental","pubTime":"2026-05-09 10:22","pubTimestamp":1778293320,"startTime":"0","endTime":"0","summary":"南方财经5月9日电，记者获悉，5月8日晚，科兴生物（SinovacBiotechLtd.）公布2025年上半年财报。财报显示，截至6月30日的六个月内，公司总销售额为1.303亿美元，较去年同期微增1.2%；但受资产减值及投资收益波动影响，归属于普通股股东的净亏损为2170万美元，而去年同期为净利润9390万美元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605093732153243.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605093732153243.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["SVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634770495","title":"科興控股上半年海外營收大增近三成，對沖國內市場下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2634770495","media":"新浪财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634770495?lang=zh_tw&edition=fundamental","pubTime":"2026-05-09 09:13","pubTimestamp":1778289180,"startTime":"0","endTime":"0","summary":"科兴控股2025年半年报显示出其业务重心的明显转移。财报显示，公司上半年海外销售额同比增长29.4%，主要得益于流感疫苗及甲肝疫苗在国际市场的出口增长。而中国内地市场受出生率下降及疫苗价格竞争影响，需求明显放缓。公司管理层在财报中表示，将坚定执行全球化战略，持续深耕海外市场。海外市场正逐步成为公司业绩的核心支撑。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/tob/2026-05-09/doc-inhxhcxp3768936.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4139","SVA"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":7,"code":"91000000","status":"200"}]}}